ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984

NCAB Says President’s Budget Would “Seriously Damage” Cancer Program

February 12, 1999

In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees

August 19, 1994

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002